Concord Medical Services ADR (CCM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -61,922 | -50,575 | -37,714 | -43,909 | -38,180 |
| Depreciation Amortization | 12,307 | 8,095 | 7,945 | 14,556 | 18,581 |
| Income taxes - deferred | -2,046 | -3,226 | 1,091 | 1,952 | 3,185 |
| Accounts receivable | -945 | 513 | 7,037 | 6,671 | 1,429 |
| Accounts payable and accrued liabilities | 1,704 | 408 | 77 | 777 | 1,003 |
| Other Working Capital | -4,996 | -10,681 | 21,472 | 8,232 | -9,128 |
| Other Operating Activity | 20,686 | 27,408 | -5,522 | 15,829 | 11,864 |
| Operating Cash Flow | $-35,212 | $-28,058 | $-5,614 | $4,108 | $-11,246 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -7,200 | 8,155 | 23,686 | N/A | 8,642 |
| PPE Investments | -25,709 | -23,465 | -7,656 | -7,472 | -9,646 |
| Net Acquisitions | 29,612 | -60,409 | -76,902 | -2,694 | 1,872 |
| Purchase Of Investment | -29,476 | -15,099 | -2,182 | -15,031 | -26,141 |
| Purchase Sale Intangibles | -1,257 | -83 | 114 | -115 | -138 |
| Other Investing Activity | -49,049 | -63,095 | -82,442 | -22,912 | 14,493 |
| Investing Cash Flow | $-81,822 | $-153,913 | $-145,496 | $-48,109 | $-10,780 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 117,547 | 41,010 | 105,701 | -14,925 | 71,666 |
| Debt Issued | 131,358 | 134,219 | 94,091 | 88,116 | 2,376 |
| Debt Repayment | -37,061 | -36,460 | -108,801 | -61,304 | -41,344 |
| Common Stock Repurchased | N/A | N/A | N/A | N/A | -4,378 |
| Dividend Paid | N/A | N/A | N/A | N/A | -41,168 |
| Other Financing Activity | -37,390 | -65,043 | 83,985 | 17,994 | -6,073 |
| Financing Cash Flow | $174,454 | $73,726 | $174,976 | $29,881 | $-18,921 |
| Exchange Rate Effect | -394 | 166 | 67 | 24 | -1,619 |
| Beginning Cash Position | 11,388 | 118,753 | 96,310 | 29,188 | 69,918 |
| End Cash Position | 68,414 | 10,674 | 120,243 | 15,092 | 27,352 |
| Net Cash Flow | $57,026 | $-108,079 | $23,933 | $-14,096 | $-42,566 |
| Free Cash Flow | |||||
| Operating Cash Flow | -35,212 | -28,058 | -5,614 | 4,108 | -11,246 |
| Capital Expenditure | -25,751 | -33,424 | -24,085 | -14,026 | -11,367 |
| Free Cash Flow | -60,963 | -61,482 | -29,699 | -9,918 | -22,613 |